Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Express Scripts
Colorcon
Dow
Harvard Business School
McKinsey

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc. (D. Del. 2010)

See Plans and Pricing

« Back to Dashboard

Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc. (D. Del. 2010)

Docket   Start Trial Date Filed 2010-10-18
Court District Court, D. Delaware Date Terminated 2012-05-25
Cause 28:1331 Fed. Question Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties GALDERMA LABORATORIES INC.; GALDERMA LABORATORIES LP; MYLAN PHARMACEUTICALS INC.; SUPERNUS PHARMACEUTICALS INC.
Patents 5,789,395; 5,919,775; 7,749,532
Attorneys David Ellis Moore; David S. Steuer; Jack B. Blumenfeld; Kirin K. Gill; Lorelei P Westin; Maryellen Noreika; Matthew R. Reed; Melissa Kopacz; Michael A. Berta; Michael D Nguyen; Richard L. Horwitz; Ron E. Shulman; Terrence Kearney; Tung-On Kong
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Mylan Pharmaceuticals Inc. v. Galderma Laboratories Inc. (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-10-18 1 Complaint U.S. Patent Nos. 7,232,572; 7,211,267; 5,789,395; and 5,919,775 (“the Ashley and Arnin patents”) in the…later~listed patent”). With respect to l\/lylan‘s ANDA 90-855,-the Ashley and Amin patents are later-listed… infringement of the Ashley and Amin patents (“the Oracea Patent Litigation”). In that complaint, GLI …the Oracea Patent Litigation is pending 22. On June 28, 2010, the Court in the Oracea Patent Litigation…Oracea Patent Litigation is scheduled for February 14-18, 2011. 25. On July 6, 2010, U,S. Patent No. 7,749,532 External link to document
2011-03-24 114 as well as No. 5,789,395 and No. 5,919,775 (the "Arnin patents"). (D.I. 93 at 1) The Ashley…4Galderma's patents are: U.S. Patent No. 7,211,267 and No. 7,232,572 (the "Ashley patents"), as… 2011. (D.1. 32) All of the patents - the Ashley patents, the Amin patents, and the Chang … not infringe a valid patent, or, if it does infringe a patent, that the patent's information has …any valid claim of U.S. Patent No. 7,749,532 (the "'532 patent,,)2 owned by Defendant Supernus External link to document
2012-05-30 179 the Commissioner of Patents and Trademarks for Patent/Trademark Number 7,749,532 B2. (Attachment: # 1… 2010 25 May 2012 1:10-cv-00892 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Merck
Express Scripts
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.